If You'd Invested $1,000 in AbbVie Stock 10 Years Ago, Here's How Much You'd Have Today

AbbVie (NYSE: ABBV) became a stand-alone, publicly traded company when it split from its former parent, Abbott Laboratories, in 2013. The reason for the split was for each company to generate greater shareholder value by focusing on its main area of expertise, which, for AbbVie, is the development and marketing of pharmaceutical products.Did the move produce the desired effect? One way to determine whether it has is to check AbbVie's performance over the past decade against that of the broader market. Let's look into that, and also try to determine if AbbVie is a worthwhile investment.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool